Table:
begin	end	state
1	1614	non-cytoplasmic

Input:
>201733
MALKDAMPSVLLENVVSLIHAKVPNSQAKQVEQFATCLYAHMSKDDLNARNDSDLYGAVL
SLWNALNKTPKGETHLRVFNPSQSKHGWQSTHSIIEVIQPDMPFLVDSVGMALNRMGITA
HVMLHTPLAIERSAQEVTKVTYLNQSPDSTEHVAVFLIEIDRQSSTADIKALEREIQSVL
ADVAASVNDWGAMSAKLSETIKELPKRPFPGEKQELEEAINFLTYLNNHHFTLLGYRQYD
LKRVEGDVELVPNIASSLGLMNKHHKTQPEQGLLLSSFSDSARKEALDHSLLILTKSSAK
SRVHRPAYVDYIGIKRFDKKGNVIGEDRFIGLYASNVYNRSPREIPLLNEKVQRVLDRSG
LTPRSHDYKALLNILENLPRDELIQANVDDLAHTAHGVLEMQDRDKLKLFVRKDGFGRFL
SCLVYVSKDRYNTKLRQDTQRILAQHFNSKEDVEFTTYFSESTLARTHYIVKVDNNNMDV
DVAAIENNLIEAARSWEDKLNTALNNALGEEAGTHLMKRYANAFEQSYKEDVLPSSAVVD
MQQLEALDDEHKLGMLFYQPQEAALNDNKVRLKLFHKDEPIHLSDVLPMLENFGLRVINE
RPYEVTTADGSTFWILDFLMTVKVVNTDNIADSQDRFQTALSQVWQKKLEDDGFNRIILA
SGLTGREVSVLRAYAKYMRQIDATFSQAYIEETFGRYPQIADLLVKMFIRKFNPKLKTRT
LGKFMEQINLRLDEVSSLDDDRIIRRYLDLINATLRTNFYQLDAKGESKSYISFKFMPSL
IPEMPRPLPKFEIFVYSPRVEGVHLRYGKVARGGLRWSDRREDFRTEVLGLVKAQQVKNT
VIVPVGAKGGFVCKQLPTEGGREAFFTEGQECYRIFIRALLDITDNILNGEIVHPVDVVR
HDEDDPYLVVAADKGTATFSDIANSISLEYNFWLGDAFASGGSNGYDHKKMGITAKGGWE
SVKRHFREVGIDCQTTDFTCLGIGDMAGDVFGNGMLLSKHTKLVAAFNHMHIFIDPNPDA
ATSYEERARLFALPRSSWEDYNSKLISKGGGVFLRSSKSIPLSAEMKQMLGTEKISMTPT
EMMKELLKMPVDLIWNGGIGTYVKSSRETNAEVGDRANDALRVNGRELRAKIVGEGGNLG
CTQLGRIEYAANGGRINTDFVDNVGGVDCSDNEVNIKILLNAMVTEGELTLKQRNRLLGE
MTEEVGEIVLQDCKDQTRTISVTQVRGAEQLKEQIRFIQYLEKEGKLDRALEFLPSEEEL
TERLANGRALTRPELSVLVAYAKMVLKEQLLTPEITEDTLLSQLLIAYFPKKLQELYSAR
MVTHPLRGEIIATSLANELVNDMGLNFVQRMQDETGASVADAAICYTMAREVFGLAELTK
SITDLNGIVPAVVQGEMLHQLRRNMRRACRWFLRHRNRSWSIEQTVAFFKPVFEQLKANV
HSYLAEEEAAGIQAEINALIKENVPQDVASTVANMSTLFSTLDIAQIAQAEEKTVALVAE
TYFKLGARVELHWFLEQISAQPVTNHWQALARAAFREELDWQQRALTSVVLRTCSATCNA
QSVISLWIETNQALLERWFHMLADFKTSQNHEFAKFSVALRELNLLILHCEGQK

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server